T3	Treatment 0 110	FK506, which began to be administered 12 days earlier, rose to a level of 44 ng/mL (normal range, 10-20 ng/mL)
T5	Effect 124 154	neurologic abnormalities began
T6	Drug 0 5	FK506
T7	Time_elapsed 38 53	12 days earlier
T4	Adverse_event 117 123	before
E1	Adverse_event:T4